Wolfgang Kauffmann

493 total citations
6 papers, 321 citations indexed

About

Wolfgang Kauffmann is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Wolfgang Kauffmann has authored 6 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Wolfgang Kauffmann's work include Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Wolfgang Kauffmann is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Wolfgang Kauffmann collaborates with scholars based in Germany, Estonia and United States. Wolfgang Kauffmann's co-authors include Michael P. Manns, Heiner Wedemeyer, Stefan Zeuzem, Markus Cornberg, Jürgen J. Wenzel, Peter Buggisch, Thomas Berg, Christos Chatzikyrkou, B. Kallinowski and Johannes Wiegand and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Molecular Medicine.

In The Last Decade

Wolfgang Kauffmann

5 papers receiving 306 citations

Peers

Wolfgang Kauffmann

HEPAT

EPIDE

ID

GENET

PHARM

Oscar G. Mandό Argentina

Mark S. Sulkowski United States

Salvatore Martini Italy

Javier Graus Spain

Laura Benítez‐Gutiérrez Spain

Evelyn Crewe Australia

Paola Zuccalà Italy

Kian Bichoupan United States

A Nanu India

P. Marks United Kingdom

Oscar G. Mandό Argentina

Wolfgang Kauffmann

192 ×0.7

HEPAT

195 ×1.3

EPIDE

76 ×0.8

ID

29 ×1.6

GENET

20 ×1.3

PHARM

Citations per year, relative to Wolfgang Kauffmann Wolfgang Kauffmann (= 1×) peers Oscar G. Mandό

Countries citing papers authored by Wolfgang Kauffmann

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Kauffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Kauffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Kauffmann more than expected).

Fields of papers citing papers by Wolfgang Kauffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Kauffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Kauffmann. The network helps show where Wolfgang Kauffmann may publish in the future.

Co-authorship network of co-authors of Wolfgang Kauffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Kauffmann. A scholar is included among the top collaborators of Wolfgang Kauffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Kauffmann. Wolfgang Kauffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pischke, Sven, Svenja Hardtke, Ulrike Bode, et al.. (2013). Ribavirin treatment of acute and chronic hepatitis E: a single‐centre experience. Liver International. 33(5). 722–726. 129 indexed citations

2.

Douros, Antonios, Wolfgang Kauffmann, Elisabeth Bronder, et al.. (2013). Ramipril-Induced Liver Injury: Case Report and Review of the Literature. American Journal of Hypertension. 26(9). 1070–1075. 20 indexed citations

3.

Sarganas, Giselle, Hans‐Dieter Orzechowski, Andreas Klimpel, et al.. (2012). Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro-Oncology. 14(5). 541–546. 22 indexed citations

4.

Pischke, Sven, Wolfgang Kauffmann, U. Bode, et al.. (2012). 565 RIBAVIRIN TREATMENT OF HEV INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: WHICH PATIENTS NEED ANTIVIRAL THERAPY?. Journal of Hepatology. 56. S224–S224.

5.

Wiegand, Johannes, Peter Buggisch, Wulf O. Boecher, et al.. (2006). Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study. Hepatology. 43(2). 250–256. 149 indexed citations

6.

Böck, H., et al.. (1964). Biochemische Befunde an Kranken mit Pilzvergiftung. Journal of Molecular Medicine. 42(21). 1039–1052. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact